133 related articles for article (PubMed ID: 24096965)
1. Growth hormone and Klotho.
Schmid C; Neidert MC; Tschopp O; Sze L; Bernays RL
J Endocrinol; 2013 Nov; 219(2):R37-57. PubMed ID: 24096965
[TBL] [Abstract][Full Text] [Related]
2. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
[TBL] [Abstract][Full Text] [Related]
3. The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.
Efthymiadou A; Kritikou D; Mantagos S; Chrysis D
Eur J Endocrinol; 2016 Apr; 174(4):473-9. PubMed ID: 26764419
[TBL] [Abstract][Full Text] [Related]
4. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
[TBL] [Abstract][Full Text] [Related]
5. Excessively high soluble Klotho in patients with acromegaly.
Sze L; Bernays RL; Zwimpfer C; Wiesli P; Brändle M; Schmid C
J Intern Med; 2012 Jul; 272(1):93-7. PubMed ID: 22452701
[TBL] [Abstract][Full Text] [Related]
6. The aging suppressor klotho: a potential regulator of growth hormone secretion.
Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
[TBL] [Abstract][Full Text] [Related]
7. Soluble α-Klotho - a new marker of acromegaly?
Jawiarczyk-Przybyłowska A; Halupczok-Żyła J; Bolanowski M
Endokrynol Pol; 2016; 67(4):390-6. PubMed ID: 27387242
[TBL] [Abstract][Full Text] [Related]
8. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
Kunert SK; Hartmann H; Haffner D; Leifheit-Nestler M
J Bone Miner Metab; 2017 Mar; 35(2):215-226. PubMed ID: 27017221
[TBL] [Abstract][Full Text] [Related]
9. The Longevity Hormone Klotho is a New Player in the Interacion of the Growth Hormone/Insulin-Like Growth Factor 1 Axis.
Rubinek T; Wolf I; Modan-Moses D
Pediatr Endocrinol Rev; 2016 Sep; 14(1):9-18. PubMed ID: 28508612
[TBL] [Abstract][Full Text] [Related]
10. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
Rubinek T; Modan-Moses D
Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
[TBL] [Abstract][Full Text] [Related]
11. Soluble delta-like 1 homolog decreases in patients with acromegaly following pituitary surgery: A potential mediator of adipogenesis suppression by growth hormone?
Sze L; Tschopp O; Neidert MC; Bernays RL; Ghirlanda C; Zwimpfer C; Wiesli P; Schmid C
Growth Horm IGF Res; 2019 Apr; 45():20-24. PubMed ID: 30818110
[TBL] [Abstract][Full Text] [Related]
12. Soluble α-klotho: a novel serum biomarker for the activity of GH-producing pituitary adenomas.
Neidert MC; Sze L; Zwimpfer C; Sarnthein J; Seifert B; Frei K; Leske H; Rushing EJ; Schmid C; Bernays RL
Eur J Endocrinol; 2013 Apr; 168(4):575-83. PubMed ID: 23360820
[TBL] [Abstract][Full Text] [Related]
13. Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism.
Kuro-o M
Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):437-41. PubMed ID: 16775459
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease.
Zhong X; Jagarlapudi S; Weng Y; Ly M; Rouse JC; McClure K; Ishino T; Zhang Y; Sousa E; Cohen J; Tzvetkova B; Cote K; Scarcelli JJ; Johnson K; Palandra J; Apgar JR; Yaddanapudi S; Gonzalez-Villalobos RA; Opsahl AC; Lam K; Yao Q; Duan W; Sievers A; Zhou J; Ferguson D; D'Antona A; Zollner R; Zhu HL; Kriz R; Lin L; Clerin V
J Biol Chem; 2020 Mar; 295(10):3115-3133. PubMed ID: 32005658
[TBL] [Abstract][Full Text] [Related]
15. Klotho gene G395A and C1818T polymorphisms in acromegaly: Association with clinical presentation and comorbidities.
Helvaci N; Kabacam S; Dagdelen S; Lay I; Karabulut E; Mut M; Alikasifoglu M; Erbas T
Clin Endocrinol (Oxf); 2021 Apr; 94(4):598-605. PubMed ID: 33296101
[TBL] [Abstract][Full Text] [Related]
16. Klotho-Dependent Cellular Transport Regulation.
Sopjani M; Dërmaku-Sopjani M
Vitam Horm; 2016; 101():59-84. PubMed ID: 27125738
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
Prié D; Friedlander G
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1717-22. PubMed ID: 20798257
[TBL] [Abstract][Full Text] [Related]
18. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
19. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
20. Soluble αKlotho as a candidate for the biomarker of aging.
Koyama D; Sato Y; Aizawa M; Maki T; Kurosawa M; Kuro-o M; Furukawa Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):1019-25. PubMed ID: 26462468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
